Variable | Study group ( | Control group ( | Result |
---|---|---|---|
85 (85.0) | 67 (67.0) | ||
(15.0) | (33.0) | ||
0 (0) | 4 (4.0) | ||
2 (2.0) | 8 (8.0) | ||
0 (0; 0–20); 0.25 (2.06) | 0 (0; 0–96); 2.96 (13.33) | ||
4 (4.0) | 13 (13.0) | ||
3 (3.0) | 5 (5.0) |
Author (year of publication) | Study population | Number of participants (study group/control group) | Employed transducers | Ultrasound- guided recruitment | Detected incidence of atelectasis | Incidence of atelectasis after RM |
---|---|---|---|---|---|---|
adults | 100/0 | convex, linear | yes | 87% | 16% | |
adults | 20/20 | convex | yes | 100% | ND | |
adults | 20/20 | convex | yes | ND | ND | |
pediatric | 61/61 | linear | yes | 21% | 13% | |
pediatric | 20/20 | linear | yes | 50% | 30% |
Variable | Study group ( | Control group ( | Result |
---|---|---|---|
63.90 (11.34) | 64.17 (14.03) | ||
28.31 (5.08) | 29.61 (5.75) | ||
Females Males | 66 (66.0) 34 (34.0) | 50 (50.0) 50 (50.0) | |
1 | 1 (1.0) | 4 (4.0) | |
2 3 | 27 (27.0) 66 (66.0) | 20 (20.0) 63 (63.0) | |
4 | 6 (6.0) | 13 (13.0) | |
0 | 49 (49.0) | 48 (57.8) | |
1 | 40 (40.0) | 20 (24.1) | |
2 | 11 (11.0) | 15 (18.1) | |
Hypertension | 55 (55.0) | 66 (66.0) | |
Ischemic heart disease | 13 (13.0) | 17 (17.0) | |
COPD | 1 (1.0) | 3 (3.0) | |
Asthma | 6 (6.0) | 2 (2.0) | |
Diabetes | 24 (24.0) | 18 (18.0) | |
Atherosclerosis | 12 (12.0) | 15 (15.0) | |
0 | 26 (26.0) | 24 (24.0) | |
1 | 26 (26.0) | 35 (35.0) | |
2 | 24 (24.0) | 23 (23.0) | |
3 | 19 (19.0) | 13 (13.0) | |
4 | 5 (5.0) | 5 (5.0) | |
Elective Emergency | 90 (90.0) 10 (10.0) | 87 (87.0) 13 (13.0) | |
<2 h | 45 (45.0) | 43 (43.0) | |
2–4 h | 44 (44.0) | 40 (40.0) | |
>4 h | 11 (11.0) | 17 (17.0) |